This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
The topics for the 5th IMI-2 Call are confirmed and the call is open
The topics for the 5th Call under the Innovative Medicines Initiative 2 are now confirmed, with a heavy emphasis on Alzheimer’s Disease (AD). The following four AD-related topics are included in the call:
– Inflammation and Alzheimer’s disease (AD): modulating microglia function – focussing on TREM2 and CD33
– Understanding the role of amyloid biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)
– Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study
– Apolipoprotein E (ApoE) biology to validated Alzheimer’s disease targets
The call is now open for stage 1 proposals with a deadline of October 13th, 2015. More information is available at the links below:
Links:
Call overview: http://www.imi.europa.eu/content/imi-2-call-5-0
Stage 1 proposals: http://www.imi.europa.eu/content/stage-1-16